Autophagy provides a conceptual therapeutic framework for bone metastasis from prostate cancer

Area of Science:

• Oncology
• Cancer Biology
• Molecular Medicine

Background:

• Prostate cancer is a leading cause of cancer death, with metastasis, particularly to bone, being the primary driver.
• Current treatments targeting pathways like the androgen receptor (AR) axis face limitations due to drug resistance and eventual metastasis.
• Understanding the complex mechanisms of metastasis is essential for developing more effective therapies.

Purpose of the Study:

• To review recent findings on the mechanisms of prostate cancer bone metastasis.
• To highlight the role of key regulatory factors, including macrophages and AKT signaling.
• To explore the significance of programmed cell death pathways, especially autophagy, in overcoming metastatic processes.

Main Methods:

• Literature review of recent studies on prostate cancer bone metastasis.
• Analysis of molecular mechanisms involving AKT, EMT, ECM, angiogenesis, and the tumor microenvironment.
• Focus on the role of programmed cell death (autophagy, apoptosis, necroptosis) in cancer cell survival during metastasis.

Main Results:

• Bone metastasis in prostate cancer is associated with significant morbidity, including fractures and pain, and reduced survival.
• Metastasis involves complex cellular processes and regulatory factors like AKT and macrophages.
• Cancer cells must overcome programmed cell death mechanisms to metastasize.

Conclusions:

• Regulating autophagy is a critical target for potentially relieving prostate cancer bone metastasis.
• Further research into multi-target treatments and novel therapeutic strategies is necessary due to limitations of current therapies.
• A deeper understanding of metastasis mechanisms, including cell death regulation, is vital for improving patient outcomes.